DK1762576T3 - Fremgangsmåde til adskillelse af alfa-1-proteinaseinhibitoren fra Cohn-fraktion IV1 plus IV4-pasta - Google Patents

Fremgangsmåde til adskillelse af alfa-1-proteinaseinhibitoren fra Cohn-fraktion IV1 plus IV4-pasta

Info

Publication number
DK1762576T3
DK1762576T3 DK06025342T DK06025342T DK1762576T3 DK 1762576 T3 DK1762576 T3 DK 1762576T3 DK 06025342 T DK06025342 T DK 06025342T DK 06025342 T DK06025342 T DK 06025342T DK 1762576 T3 DK1762576 T3 DK 1762576T3
Authority
DK
Denmark
Prior art keywords
alpha
paste
plus
separation
proteinase inhibitor
Prior art date
Application number
DK06025342T
Other languages
Danish (da)
English (en)
Inventor
Duk Sung Hwang
Evelyn Nario
Mark Lepe
Lyndon Luz
Hirokazu Ito
Kazuo Takechi
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24701177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1762576(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Application granted granted Critical
Publication of DK1762576T3 publication Critical patent/DK1762576T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Meat, Egg Or Seafood Products (AREA)
DK06025342T 1996-07-01 1997-06-27 Fremgangsmåde til adskillelse af alfa-1-proteinaseinhibitoren fra Cohn-fraktion IV1 plus IV4-pasta DK1762576T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/673,064 US5616693A (en) 1996-07-01 1996-07-01 Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
PCT/US1997/011256 WO1998000154A1 (en) 1996-07-01 1997-06-27 Process for separating alpha-1-proteinase inhibitor from cohn fraction iv1 +iv4 paste

Publications (1)

Publication Number Publication Date
DK1762576T3 true DK1762576T3 (da) 2009-04-20

Family

ID=24701177

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06025342T DK1762576T3 (da) 1996-07-01 1997-06-27 Fremgangsmåde til adskillelse af alfa-1-proteinaseinhibitoren fra Cohn-fraktion IV1 plus IV4-pasta
DK97932347T DK0944392T3 (da) 1996-07-01 1997-06-27 Fremgangsmåde til fraskillelse af alpha-1-proteinase-inhibitor fra Cohn-fraktion IV1 + IV4-pasta

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK97932347T DK0944392T3 (da) 1996-07-01 1997-06-27 Fremgangsmåde til fraskillelse af alpha-1-proteinase-inhibitor fra Cohn-fraktion IV1 + IV4-pasta

Country Status (16)

Country Link
US (2) US5616693A (cs)
EP (2) EP1762576B1 (cs)
JP (3) JP4390855B2 (cs)
KR (1) KR20000022480A (cs)
AT (2) ATE352569T1 (cs)
AU (1) AU726233B2 (cs)
BR (1) BR9710107B1 (cs)
CA (2) CA2489773A1 (cs)
CZ (3) CZ300452B6 (cs)
DE (2) DE69739212D1 (cs)
DK (2) DK1762576T3 (cs)
ES (2) ES2281104T3 (cs)
IL (1) IL127774A (cs)
PL (3) PL188830B1 (cs)
PT (2) PT944392E (cs)
WO (1) WO1998000154A1 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
AU3511500A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US6462180B1 (en) 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
WO2002048176A1 (en) 2000-12-14 2002-06-20 Bayer Corporation Method of preparing alpha-1 proteinase inhibitor
KR100406870B1 (ko) * 2001-05-25 2003-11-21 주식회사 두산 침전법을 이용한 계란 난황에서의 유용 수용성 성분의분리방법 및 침전 부산물의 이용 방법
WO2003014339A2 (en) * 2001-08-07 2003-02-20 Novozymes, A/S Carbohydrates and polyols for dissolving protein crystals
ATE420161T1 (de) * 2002-07-01 2009-01-15 Novozymes As Monopropylenglykol als fermentationszusatz
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
US7807435B2 (en) 2005-08-11 2010-10-05 Baxter International Inc. Method for the purification of alpha-1 proteinase inhibitor (a1PI)
GB0524432D0 (en) * 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
US20080124303A1 (en) * 2005-12-12 2008-05-29 Cavit Sciences, Inc Methods and compositions for treatment of viral infections
SI1999262T1 (sl) * 2006-03-30 2012-12-31 Baxter Healthcare S.A. Postopek za čiščenje rekombinantnega alfa 1-antitripsina, ki vključuje stopnjo anionske izmenjevalne kromatografije
WO2007134800A1 (en) * 2006-05-19 2007-11-29 Baxter International Inc. Ethanol dependence of alpha1 antitrypsin c-terminal lys truncation by basic carboxypeptidases
JP2014520094A (ja) 2011-05-27 2014-08-21 バクスター・インターナショナル・インコーポレイテッド 増加した半減期を有する治療用タンパク質およびそれを調製する方法
WO2012178102A2 (en) 2011-06-24 2012-12-27 The Regents Of The Unversity Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
CA2896951A1 (en) 2012-01-10 2013-07-18 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US9353165B2 (en) 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
EP2978442B1 (en) 2013-03-29 2020-03-18 The Regents of the University of Colorado, a body corporate Alpha 1 antitrypsin of use for preparing a subject for transplant
IL267923B2 (en) 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2770616A (en) * 1951-01-29 1956-11-13 Protein Foundation Inc Fractionation of proteinaceous materials in blood plasma and liver tissue
US2761808A (en) * 1952-09-06 1956-09-04 Ortho Pharma Corp Plasma fractionation process
US4056614A (en) * 1972-09-22 1977-11-01 Marc Bonneau Immunity depressant medicine
JPS52128205A (en) * 1976-04-16 1977-10-27 Green Cross Corp:The Prophylactic and therapeutic drugs for cerebro-vascular contraction
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4439358A (en) * 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4697003A (en) * 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
JPS6317899A (ja) * 1986-07-09 1988-01-25 Green Cross Corp:The ハプトグロビンの精製方法
JPS63132898A (ja) * 1986-11-26 1988-06-04 Meito Sangyo Kk 蛋白質の分離精製方法
US5093316A (en) * 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
US4829054A (en) * 1987-04-13 1989-05-09 Miles Laboratories, Inc. Method of decreasing lung damage in a host following the onset of gram negative septicemia/endotoxemia
EP0288841B1 (en) * 1987-04-27 1992-12-30 Miles Inc. Method of preparing highly purified alpha-1-proteinase inhibitor
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
US5073487A (en) * 1989-01-30 1991-12-17 Athens Research And Technology, Inc. Rapid assay for functional human α1 -proteinase inhibitor
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5610285A (en) * 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste

Also Published As

Publication number Publication date
BR9710107A (pt) 1999-08-10
CZ435698A3 (cs) 1999-05-12
PT1762576E (pt) 2009-02-02
ES2320919T3 (es) 2009-05-29
US5981715A (en) 1999-11-09
AU3583197A (en) 1998-01-21
EP0944392B1 (en) 2007-01-24
AU726233B2 (en) 2000-11-02
PL188830B1 (pl) 2005-04-29
US5616693A (en) 1997-04-01
JP2008120822A (ja) 2008-05-29
JP5245079B2 (ja) 2013-07-24
CA2259499C (en) 2006-01-24
DE69739212D1 (de) 2009-02-26
DE69737294D1 (de) 2007-03-15
ATE352569T1 (de) 2007-02-15
EP0944392A1 (en) 1999-09-29
CA2259499A1 (en) 1998-01-08
PL188873B1 (pl) 2005-05-31
CA2489773A1 (en) 1998-01-08
PT944392E (pt) 2007-04-30
BR9710107B1 (pt) 2009-05-05
ATE420111T1 (de) 2009-01-15
EP1762576A1 (en) 2007-03-14
IL127774A (en) 2005-08-31
PL330934A1 (en) 1999-06-07
IL127774A0 (en) 1999-10-28
CZ302102B6 (cs) 2010-10-13
CZ300452B6 (cs) 2009-05-20
JP4390855B2 (ja) 2009-12-24
PL188874B1 (pl) 2005-05-31
EP0944392A4 (en) 2004-11-24
DK0944392T3 (da) 2007-04-23
JP2009191076A (ja) 2009-08-27
ES2281104T3 (es) 2007-09-16
JP4588770B2 (ja) 2010-12-01
KR20000022480A (ko) 2000-04-25
DE69737294T2 (de) 2007-07-12
CZ301332B6 (cs) 2010-01-20
JP2000514647A (ja) 2000-11-07
EP1762576B1 (en) 2009-01-07
WO1998000154A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
DK1762576T3 (da) Fremgangsmåde til adskillelse af alfa-1-proteinaseinhibitoren fra Cohn-fraktion IV1 plus IV4-pasta
UA66745C2 (en) INTERLEUKIN-1b-CONVERTING ENZYME INHIBITORS, PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF DISEASES
DK0491757T3 (da) Fremgangsmåde til inaktivering af vira i blod og blodprodukter
DE60236528D1 (de) Schwach gefärbte natriumarme benzoxazinon-uv-absorber und verfahren zu ihrer herstellung
DE60021098T2 (de) Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung
ZA956314B (en) Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles
DK1362021T3 (da) Fremgangsmåde til at ekstrahere, fraktionere og oprense polyphenolforbindelser stammende fra frisk vegetabilsk affald ved anvendelse af en harpiks med höjt absorptionsudbytte og elueringsudbytte
DK0998566T3 (da) Fröplanter kendetegnet ved forsinket fröspredning
ATE375338T1 (de) Verfahren zur aufreinigung von lanzoprazol
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
DK0716067T3 (da) Fremgangsmåde til fremstilling af xylitol
DE59605765D1 (de) Verfahren zur destillation von alkoholen
FI903219A0 (fi) Menetelmä tryptofaanin puhdistamiseksi
FI20002866A0 (fi) Menetelmä maltoosin puhdistamiseksi
ATE54451T1 (de) Verfahren zum isolieren und reinigen von haemin.
DK0571742T3 (da) Fremgangmåde til fraskillelse af aminosyrer fra vandige opløsninger
EP0603671A3 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen.
WO2001049665A3 (fr) Procede de purification de lactames
DE69736180D1 (de) Behandlung von manischen erkrankungen
DE50008776D1 (de) Verfahren zur gewinnung von bakteriorhodopsin
NO20033860D0 (no) Fremgangsmåte for fjernelse av kalsium fra en sulfatopplösning i sinkprosess
ATE173503T1 (de) Die verwendung des leukozyten adhäsionsmolekül-1- aus endothelzellen und antikörper dagegen in der behandlung von asthma
DK0487480T3 (da) Fremgangsmåde til fremstilling af proteaseinhibitorer ud fra kartoffelfrugtvand
ES2117197T3 (es) Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1.
DE60010659D1 (de) Verfahren zur entfernung einer silyloxy-schutzgruppe von 4-silyloxy-tetrahydropyran-2-onen